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A B S T R A C T
Chryseobacterium species are a rare cause of human disease and are usually associated with indwelling
devices or altered immune status. This is the ﬁrst case to our knowledge, of Chryseobacterium indologenes
bacteremia in a previously healthy infant. Chryseobacteria are pathogens resistant to the usual empiric
treatments for neonatal or infantile septicemia.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Chryseobacterium species are rare human pathogens that are
found in the environment and cause a variety of infections, usually
in patients with altered immune status or in infants. This report
describes a case of Chryseobacterium indologenes bacteremia in a
healthy infant. The appropriate antibiotic choice is challenging as
the organism shows resistance to multiple antibiotics.
2. Case report
A 33-day-old female infant presented with fever of 38.8 8C and
irritability. The baby had had a greenish rhinorrhea for 2 weeks.
Normal saline drops and bulb suctioning for nasal decongestion
were prescribed by the primary care physician. The baby was born
at term by vaginal delivery. Pregnancy, birth history, and all the
maternal prenatal tests, including for HIV, were normal or
negative.
On admission the infant had normal vital signs except for fever.
She was sucking on a paciﬁer. Mild nasal congestion was noted.
The anterior fontanel was not bulging and the neck was supple.
Lung and heart auscultation were normal and the abdomen was
soft without any hepatosplenomegaly. The rest of the examination
was unremarkable. A complete blood count showed a white blood
cell (WBC) count of 19  109/l with 2% bands, 46% neutrophils, 34%* Corresponding author. Tel.: +1 718 741 2470; fax: +1 718 654 6692.
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doi:10.1016/j.ijid.2009.06.015lymphocytes and 15% monocytes. Hemoglobin levels, platelet
count, electrolytes, liver function tests, and urinalysiswere normal.
A cerebrospinal ﬂuid (CSF) analysis showed a WBC count of
2  106/l and red blood cell count of 150  106/l, glucose 59 mg/dl
and protein 26 mg/dl. Nasopharyngeal viral culture and rapid
antigen detection tests for inﬂuenza and respiratory syncytial
virus, urine and CSF cultures were all negative. Ampicillin and
cefotaxime were started empirically.
On the second day, Gram-negative bacilli were detected in the
blood culture (Bactec Systems, Becton-Dickinson) and antibiotics
were changed to cefotaxime and gentamicin. The bacilli were
further identiﬁed as Chryseobacterium indologenes, which formed
yellow colonies on agar (Fig. 1). Antimicrobial susceptibility
testing of the organism, performed by E-test (AB Biodisk), detected
resistance to ampicillin/sulbactam (>64 mg/ml), ceftriaxone
(>48mg/ml), gentamicin (>16 mg/ml), amikacin (>48mg/ml),
imipenem (>12 mg/ml), and aztreonam (>256 mg/ml) and sus-
ceptibility to piperacillin/tazobactam (<1 mg/ml), ciproﬂoxacin
(<0.75mg/ml), trimethoprim/sulfamethoxazole (<0.064 mg/ml),
and cefepime (<0.38mg/ml). Accordingly, cefepime 50 mg/kg/
dose every 12 h was given for a course of 10 days. The infant
became afebrile and her appetite improved one day after cefepime
was started and the repeat blood culture was negative.
3. Discussion
Chryseobacterium species are aerobic, oxidase-positive and non-
motile Gram-negative rods, formerly known as Flavobacterium spp.
Chryseobacteria are not part of the human ﬂora but are found inses. Published by Elsevier Ltd. All rights reserved.
Fig. 1. Buttery yellow culture of Chryseobacterium indologenes on Mueller–Hinton
agar.
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tubes, vials, disinfectants or tap water in the hospital can also
occur.2,3
The majority of the infections caused by C. indologenes have
been reported from Taiwan4 and have occurred in immunocom-
promised patients with underlying diseases, such as neoplasms,
diabetes or heart conditions.5,6 The patients frequently had
intravascular catheters or were intubated or had received
prolonged antibiotic courses. C. indologenes infections, reviewed
by Al-Tatari et al.,7 are uncommon and include ventilator-
associated pneumonia, surgical, burn wounds and ocular infec-
tions, peritonitis, and catheter and lumboperitoneal shunt infec-
tions. Forty-eight cases of C. indologenes bacteremia have been
reported in the literature,7–11 including three cases in children: a 1-
year-old boy, who after having suffered burn injuries developed
ventilator-associated pneumonia, multi-microbial bacteremia and
died;1 a 2-year-old boy with diabetic ketoacidosis and a peripheral
venous catheter,9 and a 5-month-old infant who developed C.
indologenes bacteremia postoperatively associated with contami-
nated distilled water.2 Two patients who suffered burn wounds
and had ﬁrst aid treatment with untreated water, developed C.
indologeneswound infections.12 In our case, cultures of the normalsaline nasal drops from three different containers and of the tips of
two bulb suction devices that were used, failed to grow C.
indologenes.
The antibiotic choice in cases of C. indologenes infection is
difﬁcult, as the organism shows resistance to aminoglycosides,
penicillins, aztreonam, ﬁrst-, second- and third-generation cepha-
losporins (except for ceftazidime) and variable resistance to
imipenem. The most active agents against C. indologenes in a
multicenter study were ﬂuoroquinolones and in particular
garenoxacin, gatiﬂoxacin and levoﬂoxacin, as well as piperacil-
lin/tazobactam, cefepime and trimethoprim/sulfamethoxazole.3
To our knowledge, this is the ﬁrst report of C. indologenes
bacteremia in a healthy infant. C. indologenes should be included in
the list of pathogens that may uncommonly cause bacteremia in
infants or children and are resistant to the usual empiric antibiotic
treatment. Identiﬁcation of the source of infection should be
attempted whenever possible, as this will have implications for
infection control.
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